Analysis of problems and potentials for increasing pandemic resilience in public health administrations in Saxony-Anhalt, Germany-a mixed-methods approach.

Publication date: Mar 05, 2024

The COVID-19 pandemic has shown the importance of resilient, modern, and well-equipped public health administrations from national to communal levels. In Germany, the surveillance, contact tracing, and local adaptions went through local health offices, revealing both their important role and also their lack of equipment and general preparation for health crises. Research on the mode of operation of the public health service (PHS), especially in a time of crisis, is rare. The present study aims to qualitatively and quantitatively assess problem areas, conflict potentials, and challenges that have become apparent for the PHS of Saxony-Anhalt during the pandemic. It focuses on the individual insight of employees of the PHS of Saxony-Anhalt and its 14 health offices to derive concrete needs and fields of action for increasing pandemic preparedness. Furthermore, the prospective personnel and resource-based requirements as well as the necessary structural and organisational changes of the public health departments are to be considered. The study will follow a sequential mixed-methods approach. Introductory expert interviews (n=12) with leading staff of Saxony-Anhalt’s PHS will be conducted, followed by focus group interviews (n=4) with personnel from all departments involved in the pandemic response. Thereafter, a quantitative survey will be carried out to validate and complement the results of the qualitative phase. Ethical approval was obtained by the Martin-Luther-UniversitcE4t Halle-Wittenberg ethics commission (Ref number 2023-102). The authors will submit the results of the study to relevant peer-reviewed journals and give national and international oral presentations to researchers, members of the PHS, and policymakers.

Open Access PDF

Concepts Keywords
Modern COVID-19


Type Source Name
disease MESH COVID-19 pandemic
disease IDO contact tracing
disease VO LACK
disease VO time
drug DRUGBANK Etoperidone
disease VO protocol
disease MESH emergency
disease MESH infections
drug DRUGBANK Coenzyme M
disease MESH uncertainty
disease IDO infection
drug DRUGBANK Trestolone
disease VO Gap
disease IDO history
disease VO population
disease IDO process
disease VO organ
disease IDO intervention
drug DRUGBANK Aspartame
disease IDO object
disease IDO susceptibility
pathway REACTOME Translation
drug DRUGBANK Alpha-methyltryptamine
drug DRUGBANK Diethylstilbestrol
drug DRUGBANK Rhein
drug DRUGBANK Tropicamide
disease MESH ADHD

Original Article

(Visited 1 times, 1 visits today)